Two More NovaSeq™ X Plus: CeGaT Expands Sequencing Power

With four NovaSeq™ X Plus systems now in operation, we provide the high-throughput sequencing power required to deliver fast and precise results for large-scale projects. This investment underscores our commitment […]

Weiterlesen

CeGaT Introduces CancerMRD: Personalized and Non-Invasive Tumor Monitoring

CeGaT GmbH, a global provider of genetic diagnostics and sequencing services, proudly announces the launch of CancerMRD, a new service for the individualized monitoring of minimal residual disease (MRD) in […]

Weiterlesen

CeGaT erhält als eines der ersten Unternehmen weltweit die leistungsstärkste Sequenzierplattform NovaSeq™ X Plus

CeGaT, ein global agierender Anbieter von Sequenzierdienstleistungen für Forschung, klinische Studien und humangenetische Diagnostik, setzt ab sofort das neuste und leistungsstärkste Sequenziersystem von Illumina ein. Mit dem NovaSeq™ X Plus […]

Weiterlesen

First Provider in Germany: CeGaT Offers Sequencing Services Based on PacBio’s SMRT Technology

CeGaT, a global provider of sequencing services for research, clinical trials, and human genetic diagnostics, is the first provider in Germany that has equipped its sequencing laboratory with the PacBio […]

Weiterlesen